Dalmazin, 0,075mg/ml, süstelahus hobustele, veistele, sigadele
Dalmazin, 0,075mg/ml, süstelahus hobustele, veistele, sigadele
Authorised
- R-Cloprostenol sodium
Product identification
Medicine name:
Dalmazin, 0,075mg/ml, süstelahus hobustele, veistele, sigadele
Active substance:
- R-Cloprostenol sodium
Target species:
-
Horse (mare)
-
Cattle (heifer)
-
Cattle (cow)
-
Pig (sow)
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
R-Cloprostenol sodium0.08/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Horse (mare)
-
Meat and offalno withdrawal periodMitte kasutada hobustel, kelle liha tarvitatakse inimtoiduks.
-
-
Cattle (heifer)
-
Meat and offal0day
-
-
Cattle (cow)
-
Meat and offal0day
-
Milk0day
-
-
Pig (sow)
-
Meat and offal1day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QG02AD90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Estonia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Fatro S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Fatro S.p.A.
Responsible authority:
- State Agency Of Medicines
Authorisation number:
- 1125
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Estonian (PDF)
Published on: 20/06/2023
Updated on: 26/06/2023